APA (7th ed.) Citation

Jarrin, I., Hernández‐Novoa, B., Alejos, B., Santos, I., Lopez‐Aldeguer, J., Riera, M., . . . Moreno, S. (2014). Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: Comparison of a ritonavir‐boosted protease inhibitor‐based versus a nonnucleoside reverse transcriptase inhibitor‐based first‐line regimen. HIV medicine, 15(9), 547-556. https://doi.org/10.1111/hiv.12144

Chicago Style (17th ed.) Citation

Jarrin, I., et al. "Interpreting the Reasons for the Choice and Changing of Two Drug Regimens in an Observational Cohort: Comparison of a Ritonavir‐boosted Protease Inhibitor‐based Versus a Nonnucleoside Reverse Transcriptase Inhibitor‐based First‐line Regimen." HIV Medicine 15, no. 9 (2014): 547-556. https://doi.org/10.1111/hiv.12144.

MLA (9th ed.) Citation

Jarrin, I., et al. "Interpreting the Reasons for the Choice and Changing of Two Drug Regimens in an Observational Cohort: Comparison of a Ritonavir‐boosted Protease Inhibitor‐based Versus a Nonnucleoside Reverse Transcriptase Inhibitor‐based First‐line Regimen." HIV Medicine, vol. 15, no. 9, 2014, pp. 547-556, https://doi.org/10.1111/hiv.12144.